Log In
Print
BCIQ
Print
Print this Print this
 

naproxcinod (HCT 3012)

Also known as: formerly AZD3582

  Manage Alerts
Collapse Summary General Information
Company Nicox S.A.
DescriptionCyclooxygenase (COX)-inhibiting nitric oxide donator (CINOD) that releases naproxen and nitric oxide (NO)
Molecular Target Cyclooxygenases (COX)
Mechanism of ActionNitric oxide (NO)-releasing NSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationOsteoarthritis
Indication DetailsTreat osteoarthritis (OA) of the hip; Treat osteoarthritis (OA) of the hip and/or knee in hypertensive patients; Treat osteoarthritis (OA) of the knee; Treat signs and symptoms of osteoarthritis (OA)
Regulatory Designation U.S. - Undisclosed Review (Treat osteoarthritis (OA) of the knee)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today